In the females, the top two pathways that changed with IUGR were serotonin receptor signaling and dopamine receptor signaling (Figure 5G), with corresponding genes such as Htr1a, Ddc, and Drd2 being associated with these pathways (Table S7). The gene discussed is HTR1A; the disease is fetal growth restriction.